(Press-News.org) In 2003 in Haiti, a 20-year-old in treatment for HIV could have expected to live to 34. But as of 2017, life expectancy for a 20-year-old in treatment for HIV in Haiti is now 61, compared to 70 for Haiti's general population.
A research team from Vanderbilt University Medical Center and institutions across Latin America today reports what looks to be far the largest study to date of life expectancy for people living with HIV infection in low-income or middle-income countries.
With a focus on 30,688 people treated for HIV between 2003 and 2017 in seven Latin American countries, the study, published in The Lancet HIV, finds dramatic increases in life expectancy.
In 2003, a 20-year-old in treatment for HIV in Argentina, Brazil, Chile, Honduras, Mexico or Peru could have expected to live to 51. As of 2017, life expectancy for a 20-year-old in treatment for HIV in these countries is 70, compared to 78 for the general population.
Data used in the study came from the Caribbean, Central, and South America Network for HIV Epidemiology (CCASAnet), an HIV epidemiology research consortium that links VUMC expertise and resources with researchers at clinical sites in Argentina, Brazil, Chile, Haiti, Honduras, Mexico and Peru.
While reflecting the increased use of antiretroviral therapy to treat HIV infection in low-income and middle-income countries, the gains found in the study also track with overall gains in life expectancy in the region. The greatest gains in life expectancy for those with HIV came in the years 2013 through 2017, coinciding with the "treat all" era in HIV, whereby all people with HIV are recommended to received treatment regardless of HIV disease stage.
"Antiretroviral therapy became much more widely available across the study region beginning in the 2000s, and it gives one heart to see the widespread effect this is having," said one of the leaders of the study, infectious diseases specialist Jessica Castilho, MD, MPH, assistant professor of Medicine at VUMC.
"Our findings, however, also highlight stark health disparities within the HIV population in these countries, echoing the situation in the U.S. and other high-income countries. These disparities are like cracks showing in the system of care and prevention. Our findings in this regard could help steer the public health response to HIV in the region."
Among people with HIV, the study found differences in life expectancy based on sex, HIV transmission risk factors (things like sexual preference and injection drug use), history of tuberculosis, level of education, and how severe HIV infection had become by the start of therapy (as measured by CD4 cell count, an index of the immune response).
Throughout the retrospective 14-year study period, life expectancy was generally higher among women with HIV than men with HIV who have sex with men or heterosexual men with HIV.
A study in the U.S. population, published last year in JAMA Network Open, used age, sex and ethnicity to match 39,000 people living with HIV with 10 times as many people who were free of the infection. The study found that, from 2000 to 2016, the gap in life expectancy in the U.S. for those with HIV had shrunk from 22 fewer years of life to 7 fewer years.
INFORMATION:
Others on the study from VUMC include lead author Casey Smiley, MD, Peter Rebeiro, PhD, and CCASAnet's principal investigator, Catherine McGowan, MD. They were joined by researchers from Weill Cornell Medical College and universities and public health authorities in the CCASAnet countries.
CCASAnet is funded in large part by the National Institutes of Health (AI069923).
Study of 30,000 adults living with HIV receiving antiretroviral therapy (ART) in Latin America and the Caribbean finds life expectancy has increased to within 10 years of the general population in these countries over the last two decades.
Disparities in life expectancy due to demographic and clinical factors at the point participants began ART (including sexual HIV transmission risk, low CD4 cell count, and history of tuberculosis) highlight an ongoing need to reach vulnerable populations in the region.
Life expectancy among adults living with HIV receiving antiretroviral therapy (ART) ...
When disease outbreaks happen, response time in developing and distributing treatments is crucial to saving lives. Unfortunately, developing custom drugs as countermeasures is often a slow and difficult process.
But researchers at the University of Colorado Boulder have created a platform that can develop effective and highly specific peptide nucleic acid therapies for use against any bacteria within just one week. The work is detailed in Nature Communications Biology and could change the way we respond to pandemics and how we approach increasing cases of antibiotic resistance globally.
The Facile Accelerated Specific Therapeutic (FAST) platform was created by Associate Professor Anushree Chatterjee ...
Researchers at the University of Jyväskylä highlight how the struggles caused by the COVID-19 pandemic can guide us towards an equitable use of our shared environment and a transition towards sustainability.
COVID-19 crisis has emphasized how poorly prepared humanity is to cope with global disasters and to face the new ecological norm under climate change, degraded ecosystems, and biodiversity loss. The final consequences of COVID-19 crisis on sustainability are not yet known. However, this crisis offers a unique opportunity to move towards a greener, ...
Coral reefs around the world are under threat from rising sea temperatures, ocean acidification, disease and overfishing, among other reasons.
Tracking signs of stress and ill health is difficult because corals -- an animal host coexisting with algae, bacteria, viruses and fungi -- are dynamic organisms that behave differently depending on what's happening in their environment. Some scientists wonder if recording changes in coral movements over time could help with monitoring a coral reef's health.
This is not always a straightforward task. Some coral species wave and pulse in ...
Just as e-cigarette ingredients can vary from one region to another, the health effects of vaping can have regional characteristics as well. A new study out of West Virginia University suggests that rural e-cigarette users are older--and often get sicker--than their urban counterparts.
Researchers with the WVU School of Medicine are investigating severe lung injuries occurring among e-cigarette users in rural Appalachia. In a recent study, Sunil Sharma--section chief of pulmonary/critical care and sleep medicine at the School of Medicine--and his colleagues present a case study of patients with EVALI (electronic cigarettes and vaping-associated lung injury) admitted to WVU hospitals from August 2019 to March 2020. ...
Like a stern bodyguard for the central nervous sytem, the blood-brain barrier keeps out anything that could lead to disease and dangerous inflammation--at least when all is functioning normally.
That may not be the case in people with schizophrenia and other mental disorders, suggest new findings from a team led by researchers from the School of Veterinary Medicine, Perelman School of Medicine, and Children's Hospital of Philadelphia (CHOP). In these individuals, a more permissive barrier appears to allow the immune system to get improperly involved in the central nervous system, the researchers showed. The inflammation that arises likely contributes to the clinical manifestations of neuropsychiatric conditions.
"Our hypothesis was that, if the immune function of the blood-brain ...
WASHINGTON -- Researchers have developed new x-ray optics that can be used to harness extremely fast pulses in a package that is significantly smaller and lighter than conventional devices used to modulate x-rays. The new optics are based on microscopic chip-based devices known as microelectromechanical systems (MEMS).
"Our new ultrafast optics-on-a-chip is poised to enable x-ray research and applications that could have a broad impact on understanding fast-evolving chemical, material and biological processes," said research team leader Jin Wang from the U.S Department of Energy's Argonne National Laboratory. "This could aid in the development of more efficient solar cells and batteries, advanced computer storage materials and devices, ...
Engineered, autonomous machines combined with artificial intelligence have long been a staple of science fiction, and often in the role of villain like the Cylons in the "Battlestar Galactica" reboot, creatures composed of biological and engineered materials. But what if these autonomous soft machines were ... helpful?
This is the vision of a team of Penn State and U.S. Air Force researchers, outlined in a recent paper in Nature Communications. These researchers produced a soft, mechanical metamaterial that can "think" about how forces are applied to it and respond via programmed reactions. ...
People who regularly use psychoactive substances report experiencing a variety of negative impacts since the COVID-19 pandemic began, including increased usage and fear of relapse or overdose, highlighting the need for improved supports and services, including better access to safe supply programs, according to a new CAMH survey published in the International Journal of Drug Policy.
"People who use drugs have been negatively impacted by the pandemic in ways that put them at greater risk for experiencing substance and health-related harms, including overdoses and a decreased ability to mitigate risk behaviours," ...
Leesburg, VA, April 20, 2021--An award-winning Scientific Electronic Exhibit to be presented at the ARRS 2021 Virtual Annual Meeting found non-contrast pituitary MRI for central precocious puberty (CPP), growth hormone deficiency (GHD), and short stature (SS) has similar diagnostic yield compared to the standard contrast-enhanced protocol.
"Microadenomas, a common justification for contrast administration, may not influence management in this patient population," wrote first author Jennifer Huang of Vanderbilt University in Nashville, TN, adding "minimal inconvenience would be added for the few patients who would need to return for contrast-enhanced MRI for definitive diagnosis."
Huang and colleagues performed a retrospective review of pediatric pituitary MRI studies from 2010-2019 ...
